On the question of potential interactions between APOE genotype and selenium level for the development of dyslipidemia, animal studies demonstrated that selenium supplementation was responsible for down regulation of apoB expression during hypercholesterolemia [54, 55], and could increase the LDL-receptor activity [56,57]. Here, APOB is linked to familial hypercholesterolemia.